Cargando…

Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis

Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC). We investigated the significance of skeletal muscle volume and its changes in LC patients taking levocarnitine (L-carnitine). We retrospectively analyzed 51 LC patients taking L-carnitine from December 2012 to M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Masashi, Abe, Kazumichi, Hayashi, Manabu, Takahashi, Atsushi, Ohira, Hiromasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360248/ https://www.ncbi.nlm.nih.gov/pubmed/32664122 http://dx.doi.org/10.1097/MD.0000000000021061

Ejemplares similares

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy
por: Abe, Kazumichi, et al.
Publicado: (2021)

Changes in platelet levels and prognosis in patients with acute liver failure and late-onset hepatic failure
por: Hayashi, Manabu, et al.
Publicado: (2022)

Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia
por: Hayashi, Manabu, et al.
Publicado: (2018)

Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Hepatitis B Virus Reactivation in a Patient with Nonalcoholic Steatohepatitis 41 Months after Rituximab-containing Chemotherapy
por: Hayashi, Manabu, et al.
Publicado: (2018)

Association between serum ficolin-1 level and disease progression in primary biliary cholangitis
por: Hayashi, Manabu, et al.
Publicado: (2020)

Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis
por: Hayashi, Manabu, et al.
Publicado: (2022)

Quality of life among patients with autoimmune hepatitis in remission: A comparative study
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease
por: Abe, Kazumichi, et al.
Publicado: (2018)

Interleukin‐33/ST2‐Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2019)

Endogenous Endophthalmitis Associated with Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
por: Fujita, Masashi, et al.
Publicado: (2019)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

Intratumor Abscess in a Posttraumatic Hepatic Inflammatory Pseudotumor Spreading Out of the Liver
por: Hayashi, Manabu, et al.
Publicado: (2020)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
por: Fujita, Masashi, et al.
Publicado: (2022)

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019)

Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization
por: Fujita, Masashi, et al.
Publicado: (2019)

Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt
por: Hayashi, Manabu, et al.
Publicado: (2020)

Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
por: Zhou, Jing, et al.
Publicado: (2019)

Significance of Levocarnitine Treatment in Dialysis Patients
por: Takashima, Hiroyuki, et al.
Publicado: (2021)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report
por: Xia, Jie, et al.
Publicado: (2018)

Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2020)

Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer
por: Ma, Junxun, et al.
Publicado: (2017)

High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer
por: Meng, Jiyu, et al.
Publicado: (2023)

Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies
por: Peng, Ying, et al.
Publicado: (2016)

Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis
por: Xian, Jianchun, et al.
Publicado: (2021)

Pancreatic progenitor cell differentiation and proliferation factor predicts poor prognosis in heptaocellular carcinoma
por: Mao, Zhengfa, et al.
Publicado: (2019)

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer
por: Lu, Wei, et al.
Publicado: (2015)

Poor prognosis of liver transplantation for acute liver failure with acute pancreatitis: Two case reports
por: Yan, Liting, et al.
Publicado: (2020)

Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy
por: Takahashi, Atsushi, et al.
Publicado: (2017)

Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
por: Takahashi, Atsushi, et al.
Publicado: (2020)

The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2021)

Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer
por: Kang, Yue, et al.
Publicado: (2015)

Effects of Levocarnitine Treatment on the Cardiac Function in Hemodialysis Patients
por: Maruyama, Takashi, et al.
Publicado: (2018)

Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2016)

Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma
por: Tu, Jian-Fei, et al.
Publicado: (2016)

Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma
por: Wang, Lingxiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6cs97l4relutphai20n8kclvnk